Since MERS-CoV binds to DPP4, a transgenic mouse model expressing human DPP4 on relevant cells as epithelial and alveolar pulmonary cells has been used to study the impact of diabetes on MERS-CoV infection. This evidence concerns the gene DPP4 and diabetes mellitus.